IMP2 supports glycolytic functions in FLT3-ITD-positive acute myeloid leukemia (AML), a common and aggressive form of AML characterized by an internal tandem duplication mutation in the FLT3 gene [101]. This evidence concerns the gene IGF2BP2 and acute myeloid leukemia.